newsfilter
← Latest News
GlobeNewswire·

GT Biopharma Reports First Quarter 2026 Financial Results

Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with additional updates anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to express B7-H3